Illumina Acquires Edico Genome

May 15, 2018

|

NEW YORK (GenomeWeb) – Illlumina said today that it has acquired data analysis firm Edico Genome.

Edico markets its DRAGEN platform, which uses field programmable gate array technology in combination with proprietary software algorithms to reduce data footprint and enable faster speeds. Users can run DRAGEN on site, in the cloud or in a hybrid mode, and can use a variety of different cloud storage solutions and analysis pipelines.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Open Spot

Politico notes that the Biden Administration has not yet nominated a permanent Food and Drug Administration commissioner.

US to Remain in WHO

Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.

Dip Possible

A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.

Nature Papers Examine Australian Lungfish Genome, Essential E. Coli Genes

In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.

Featured White Papers

In-depth Quantification of Cell and Gene Therapy DNA Integrations Enabled with Single-cell Sequencing

Deep Understanding of Cell and Gene Therapy Genome Editing Protocols Enabled With Single-cell Sequencing

Illuminating the Role of the Adaptive Immune Response in Neurodegeneration

Transcriptional Profiling of 1.3 Million Brain Cells with the Chromium Single Cell Gene Expression Solution

Jan

26

Featured Webinar

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Reduced representation next-generation sequencing (NGS) methods are driving understanding of both physical and structural variation in all species.

Jan

28

Featured Webinar

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

This webinar discusses how the University of Michigan has implemented a new next-generation sequencing (NGS) capture-based solution to assess myeloid malignancies while minimizing required laboratory resources.

Feb

11

Featured Webinar

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

In this session, the first in the Precision Oncology News Virtual Molecular Tumor Board Series, our expert panelists will review patient cases in which genomic profiling has identified biomarkers related to homologous recombination deficiency and DNA damage repair.

Feb

17

Featured Webinar

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Host immune responses play a central role in controlling SARS-CoV-2 infection, but they remain incompletely characterized and understood.

Menu

Illumina Acquires Edico Genome

To read the full story....

Breaking News

Fluidigm Obtains CE Mark for Saliva-Based SARS-CoV-2 Assay

Skin Cell Atlas Elucidates Pathological Cell States Underlying Inflammatory Skin Diseases

Lung Cancer Metastasis Study Relies on CRISPR-Based Method to Track Single-Cell Lineages

Breast Cancer Risk Gene Associations Refined in Large-Scale Studies

Genetic Technologies to Raise $6.6M in Direct Offering

CareDx Prices $175M Common Stock Offering

The Scan

Open Spot

US to Remain in WHO

Dip Possible

Nature Papers Examine Australian Lungfish Genome, Essential E. Coli Genes

Featured White Papers

Panel Discussion: Genotyping by Sequencing for Novel SNP Discovery with Less Common Genomes

Implementation of a Customized Myeloid NGS-based Solution in an Academic Clinical Laboratory

Virtual Molecular Tumor Board Series: HRD and DNA Damage Repair

Single-Cell Multiomics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

What's Popular?

Illumina Wins UK Patent Infringement Suit Against BGI, Affiliates

Ancestry Shutters Health Offering, Raising Questions About Future of Consumer Genomics

Lung Cancer Metastasis Study Relies on CRISPR-Based Method to Track Single-Cell Lineages

Breast Cancer Risk Gene Associations Refined in Large-Scale Studies

Quest Diagnostics Wins CDC Contract to Sequence SARS-CoV-2 Samples

Sponsorships